Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
As of today, Eli Lilly(LLY) shares are valued at $1,082.59. The company's market cap stands at 1.02T, with a P/E ratio of 53.78 and a dividend yield of 55.2%.
On 2026-01-23, Eli Lilly(LLY) stock moved within a range of $1,063.02 to $1,091.00. With shares now at $1,082.59, the stock is trading +1.8% above its intraday low and -0.8% below the session's peak.
Trading volume for Eli Lilly(LLY) stock has reached 447.03K, versus its average volume of 2.89M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
LLY News
Why Eli Lilly Is The IBD Stock Of The Day — Again — As Its Novo Nordisk Rivalry Deepens 1/21/2026 Eli Lilly is Wednesday's IBD Stock Of The Day. Lilly shares a...
Wall Street brokerage Bernstein sees Eli Lilly’s (LLY) stock hitting $1,300 per share. Claim 50% Off TipRanks Premium Analysts at Bernstein have reiterated a...
Eli Lilly (NYSE:LLY) received FDA Breakthrough Therapy designation for sofetabart mipitecan in platinum resistant ovarian cancer. The company also announced ne...
Analyst ratings
80%
of 30 ratingsMore LLY News
Key Points Top executives from drugmakers big and small told CNBC that the next phase of the obesity drug market will be defined by a broader range of treatment...
This biotech has candidates in late-stage clinical development. Eli Lilly (LLY +0.82%) delivered a gain worthy of a technology growth stock last year. The phar...
Pharma giants Eli Lilly (LLY) and Novo Nordisk (NVO) will face further competition in the crucial obesity drug market in India, as the country’s top drugmaker S...
Is the 2026 Market Rotation Already Underway? Here’s What Could Lead After the Magnificent 7 Quick Read Magnificent Seven stocks are in the red for 2026 as col...
Image source: The Motley Fool. Aug. 7, 2025 at 8:30 a.m. ET Call participants Chairman and Chief Executive Officer — David A. Ricks Chief Financial Officer — L...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium Eli Lilly’s new Phase 1 imaging study, officia...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and powerful invest...